NasdaqGS - Nasdaq Real Time Price USD

ImmunityBio, Inc. (IBRX)

2.7300
-0.1100
(-3.87%)
As of 11:42:30 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
31,222
14,745
622
240
934
Cost of Revenue
58
0
0
0
--
Gross Profit
31,164
14,745
622
240
--
Operating Expense
344,579
358,927
361,986
350,857
331,214
Operating Income
-313,415
-344,182
-361,364
-350,617
-330,280
Net Non Operating Interest Income Expense
-142,945
-151,927
-128,335
-60,807
-14,013
Other Income Expense
46,945
82,464
-94,193
-5,862
-5,546
Pretax Income
-409,415
-413,645
-583,892
-417,286
-349,839
Tax Provision
-234
0
-40
34
9
Net Income Common Stockholders
-409,101
-413,564
-583,196
-416,567
-346,790
Diluted NI Available to Com Stockholders
-409,101
-413,564
-583,196
-416,567
-346,790
Basic EPS
-0.54
-0.59
-1.15
-1.04
-0.89
Diluted EPS
-0.57
-0.62
-1.15
-1.04
-0.89
Basic Average Shares
742,394.7500
697,312
508,636
399,900
389,234.1560
Diluted Average Shares
745,525.7500
700,443
508,636
399,900
389,234.1560
Total Operating Income as Reported
-313,415
-344,182
-362,250
-351,298
-330,280
Total Expenses
344,637
358,927
361,986
350,857
331,214
Net Income from Continuing & Discontinued Operation
-409,101
-413,564
-583,196
-416,567
-346,790
Normalized Income
-455,165.6568
-452,571
-534,981.3032
-422,081.9900
-343,186.7200
Interest Income
2,760
2,400
863
2,708
836
Interest Expense
128,585
131,658
86,717
47,145
14,849
Net Interest Income
-142,945
-151,927
-128,335
-60,807
-14,013
EBIT
-280,830
-281,987
-497,175
-370,141
-334,990
EBITDA
-264,002
-264,433
-478,663
-351,881
-320,752
Reconciled Cost of Revenue
58
0
0
0
--
Reconciled Depreciation
16,828
17,554
18,512
18,260
14,238
Net Income from Continuing Operation Net Minority Interest
-409,101
-413,564
-583,196
-416,567
-346,790
Total Unusual Items Excluding Goodwill
46,091
39,007
-48,218
6,981
-4,936
Total Unusual Items
46,091
39,007
-48,218
6,981
-4,936
Normalized EBITDA
-310,093
-303,440
-430,445
-358,862
-315,816
Tax Rate for Calcs
0
0
0
0.0002
0.0003
Tax Effect of Unusual Items
26.3432
0
-3.3032
1,466.0100
-1,332.7200
12/31/2021 - 7/28/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IOVA Iovance Biotherapeutics, Inc.
1.7150
+3.31%
 
CTMX CytomX Therapeutics, Inc.
2.1750
+7.13%
 
SMMT Summit Therapeutics Inc.
23.19
-2.87%
 
BLUE bluebird bio, Inc.
4.9800
+0.20%
 
SGMO Sangamo Therapeutics, Inc.
0.4651
-1.04%
 
ARDX Ardelyx, Inc.
3.9300
+1.29%
 
VKTX Viking Therapeutics, Inc.
27.12
-4.61%
 
TGTX TG Therapeutics, Inc.
33.97
-1.14%
 
ALT Altimmune, Inc.
5.44
-2.51%
 
CADL Candel Therapeutics, Inc.
5.30
-0.93%